These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33348127)

  • 1. Morphological, functional, and molecular assessment of breast cancer bone metastases by experimental ultrasound techniques compared with magnetic resonance imaging and histological analysis.
    Heinen H; Seyler L; Popp V; Hellwig K; Bozec A; Uder M; Ellmann S; Bäuerle T
    Bone; 2021 Mar; 144():115821. PubMed ID: 33348127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-modal imaging of angiogenesis in a nude rat model of breast cancer bone metastasis using magnetic resonance imaging, volumetric computed tomography and ultrasound.
    Bäuerle T; Komljenovic D; Berger MR; Semmler W
    J Vis Exp; 2012 Aug; (66):e4178. PubMed ID: 22929330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative contrast-enhanced ultrasound for imaging antiangiogenic treatment response in experimental osteolytic breast cancer bone metastases.
    Merz M; Komljenovic D; Semmler W; Bäuerle T
    Invest Radiol; 2012 Jul; 47(7):422-9. PubMed ID: 22659593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-Enhanced Ultrasound with VEGFR2-Targeted Microbubbles for Monitoring Regorafenib Therapy Effects in Experimental Colorectal Adenocarcinomas in Rats with DCE-MRI and Immunohistochemical Validation.
    Eschbach RS; Clevert DA; Hirner-Eppeneder H; Ingrisch M; Moser M; Schuster J; Tadros D; Schneider M; Kazmierczak PM; Reiser M; Cyran CC
    PLoS One; 2017; 12(1):e0169323. PubMed ID: 28060884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of conventional ultrasound, contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging in assessing the size of breast cancer.
    Shi XQ; Dong Y; Tan X; Yang P; Wang C; Feng W; Lin Y; Qian L
    Clin Hemorheol Microcirc; 2022; 82(2):157-168. PubMed ID: 35723092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging anti-angiogenic treatment response with DCE-VCT, DCE-MRI and DWI in an animal model of breast cancer bone metastasis.
    Bäuerle T; Bartling S; Berger M; Schmitt-Gräff A; Hilbig H; Kauczor HU; Delorme S; Kiessling F
    Eur J Radiol; 2010 Feb; 73(2):280-7. PubMed ID: 19070445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-dimensional contrast enhanced ultrasound score and dynamic contrast-enhanced magnetic resonance imaging score in evaluating breast tumor angiogenesis: correlation with biological factors.
    Jia WR; Chai WM; Tang L; Wang Y; Fei XC; Han BS; Chen M
    Eur J Radiol; 2014 Jul; 83(7):1098-1105. PubMed ID: 24794865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted imaging and dynamic contrast-enhanced MRI of experimental breast cancer bone metastases--a correlation study with histology.
    Merz M; Seyler L; Bretschi M; Semmler W; Bäuerle T
    Eur J Radiol; 2015 Apr; 84(4):623-30. PubMed ID: 25641009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-Animal Comparison between Three-dimensional Molecularly Targeted US and Three-dimensional Dynamic Contrast-enhanced US for Early Antiangiogenic Treatment Assessment in Colon Cancer.
    Wang H; Lutz AM; Hristov D; Tian L; Willmann JK
    Radiology; 2017 Feb; 282(2):443-452. PubMed ID: 27490690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benign and malignant breast lesions: efficacy of real time contrast-enhanced ultrasound vs. magnetic resonance imaging.
    Ricci P; Cantisani V; Ballesio L; Pagliara E; Sallusti E; Drudi FM; Trippa F; Calascibetta F; Erturk SM; Modesti M; Passariello R
    Ultraschall Med; 2007 Feb; 28(1):57-62. PubMed ID: 17304413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiating benign from malignant solid breast lesions: combined utility of conventional ultrasound and contrast-enhanced ultrasound in comparison with magnetic resonance imaging.
    Du J; Wang L; Wan CF; Hua J; Fang H; Chen J; Li FH
    Eur J Radiol; 2012 Dec; 81(12):3890-9. PubMed ID: 23062280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative Three-Dimensional Dynamic Contrast-Enhanced Ultrasound Imaging: First-In-Human Pilot Study in Patients with Liver Metastases.
    El Kaffas A; Sigrist RMS; Fisher G; Bachawal S; Liau J; Wang H; Karanany A; Durot I; Rosenberg J; Hristov D; Willmann JK
    Theranostics; 2017; 7(15):3745-3758. PubMed ID: 29109773
    [No Abstract]   [Full Text] [Related]  

  • 14. Early Prediction of Response to Neoadjuvant Chemotherapy Using Dynamic Contrast-Enhanced MRI and Ultrasound in Breast Cancer.
    Kim Y; Kim SH; Song BJ; Kang BJ; Yim KI; Lee A; Nam Y
    Korean J Radiol; 2018; 19(4):682-691. PubMed ID: 29962874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasound Molecular Imaging With BR55, a Predictive Tool of Antiangiogenic Treatment Efficacy in a Chemo-Induced Mammary Tumor Model.
    Helbert A; Von Wronski M; Colevret D; Botteron C; Padilla F; Bettinger T; Tardy I; Hyvelin JM
    Invest Radiol; 2020 Oct; 55(10):657-665. PubMed ID: 32229739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cilengitide inhibits progression of experimental breast cancer bone metastases as imaged noninvasively using VCT, MRI and DCE-MRI in a longitudinal in vivo study.
    Bäuerle T; Komljenovic D; Merz M; Berger MR; Goodman SL; Semmler W
    Int J Cancer; 2011 May; 128(10):2453-62. PubMed ID: 20648558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative correlational study of microbubble-enhanced ultrasound imaging and magnetic resonance imaging of glioma and early response to radiotherapy in a rat model.
    Yang C; Lee DH; Mangraviti A; Su L; Zhang K; Zhang Y; Zhang B; Li W; Tyler B; Wong J; Wang KK; Velarde E; Zhou J; Ding K
    Med Phys; 2015 Aug; 42(8):4762-72. PubMed ID: 26233204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of diffusion-weighted, intravoxel incoherent motion, and dynamic contrast-enhanced MR imaging in the assessment of response to radiotherapy of lytic bone metastases from breast cancer.
    Gaeta M; Benedetto C; Minutoli F; D'Angelo T; Amato E; Mazziotti S; Racchiusa S; Mormina E; Blandino A; Pergolizzi S
    Acad Radiol; 2014 Oct; 21(10):1286-93. PubMed ID: 25088834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of granulocyte colony-stimulating factor on bone marrow: evaluation by intravoxel incoherent motion and dynamic contrast-enhanced magnetic resonance imaging.
    Minutoli F; Pergolizzi S; Blandino A; Mormina E; Amato E; Gaeta M
    Radiol Med; 2020 Mar; 125(3):280-287. PubMed ID: 31823293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
    Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
    Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.